Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel J Hogan

Showing results (41-50 of 42) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 42 results.
Neuro-Oncology|May 16, 2018
Durable complete responses in some recurrent high-grade glioma patients treated with Toca 511 + Toca FCTimothy F Cloughesy, Joseph Landolfi, Michael A Vogelbaum, et al.
Science Translational Medicine|June 3, 2016
Phase 1 trial of vocimagene amiretrorepvec and 5-fluorocytosine for recurrent high-grade gliomaTimothy F Cloughesy, Joseph Landolfi, Daniel J Hogan, et al.
Pageof 5

Showing results (41-50 of 42) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 42 results.
Neuro-Oncology|May 16, 2018
Durable complete responses in some recurrent high-grade glioma patients treated with Toca 511 + Toca FCTimothy F Cloughesy, Joseph Landolfi, Michael A Vogelbaum, et al.
Science Translational Medicine|June 3, 2016
Phase 1 trial of vocimagene amiretrorepvec and 5-fluorocytosine for recurrent high-grade gliomaTimothy F Cloughesy, Joseph Landolfi, Daniel J Hogan, et al.
Pageof 5